UnitedHealth Group (NYSE:UNH) Shares Up 1.5% – Here’s What Happened

Shares of UnitedHealth Group Incorporated (NYSE:UNHGet Free Report) rose 1.5% on Wednesday . The company traded as high as $328.73 and last traded at $328.40. Approximately 5,874,134 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 11,868,669 shares. The stock had previously closed at $323.60.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. KeyCorp boosted their price target on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. UBS Group increased their price target on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Royal Bank Of Canada upped their price objective on UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Seventeen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Hold” and a consensus target price of $385.54.

Read Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

The firm’s 50 day simple moving average is $340.93 and its 200 day simple moving average is $316.37. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The firm has a market cap of $297.48 billion, a PE ratio of 17.14, a PEG ratio of 2.11 and a beta of 0.43.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter in the prior year, the firm earned $7.15 earnings per share. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a yield of 2.7%. UnitedHealth Group’s payout ratio is 46.14%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the business. Bayforest Capital Ltd lifted its stake in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its position in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 50 shares during the last quarter. LFA Lugano Financial Advisors SA bought a new position in shares of UnitedHealth Group in the second quarter worth about $25,000. Foster Dykema Cabot & Partners LLC lifted its holdings in UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 34 shares in the last quarter. Finally, 1248 Management LLC purchased a new position in shares of UnitedHealth Group during the third quarter worth approximately $29,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.